{"id":"W2082461176","doi":"10.1002/ana.22316","title":"Phase III dose‐comparison study of glatiramer acetate for multiple sclerosis","year":2010,"lang":"en","type":"article","venue":"Annals of Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Teva Pharmaceutical Industries","keywords":"Glatiramer acetate; Medicine; Tolerability; Multiple sclerosis; Clinical endpoint; Confidence interval; Expanded Disability Status Scale; Internal medicine; Randomized controlled trial; Magnetic resonance imaging; Adverse effect; Radiology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004715255,0.0001847563,0.0008857787,0.0002256629,0.00007967707,0.000005109293,0.0002131939,0.0001140506,0.00006363129],"category_scores_gemma":[0.001617062,0.0001544016,0.0001774851,0.0002018154,0.0003226076,0.00005994032,0.0001555458,0.0004084714,0.000005582131],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000001550476,"about_ca_system_score_gemma":0.00003680137,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002712782,"about_ca_topic_score_gemma":0.0004410467,"domain_scores_codex":[0.9980715,0.000114201,0.0006636024,0.0003814291,0.0003318408,0.0004374466],"domain_scores_gemma":[0.9975675,0.0008659948,0.0003030124,0.0005400947,0.0005757494,0.0001476147],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.01131141,0.01202202,0.1317866,0.0001587773,0.0005208217,0.00000705025,0.002040118,0.00003027872,0.7896726,0.00003236939,0.006569796,0.0458482],"study_design_scores_gemma":[0.05709676,0.03995177,0.7479143,0.00003444184,0.0002007841,0.000006842152,0.0005268797,0.006451552,0.1333382,0.00005760403,0.01416033,0.0002605473],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940694,0.00008227112,0.00004900133,0.003729713,0.0002138889,0.00163877,0.00004446568,0.00002924318,0.000143247],"genre_scores_gemma":[0.9985734,0.0001120476,0.0003834867,0.0005820299,0.0001143535,0.0001503831,0.00001121841,0.00002842993,0.00004468637],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6563343,"threshold_uncertainty_score":0.6296316,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.307229721040198,"score_gpt":0.4531105052399868,"score_spread":0.1458807841997888,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}